Amanda F Dempsey1,2, Jennifer Pyrznawoski1, Steven Lockhart1, Juliana Barnard1, Elizabeth J Campagna1, Kathleen Garrett3, Allison Fisher4, L Miriam Dickinson1,5, Sean T O'Leary1,6. 1. Adult and Child Consortium for Outcomes Research and Dissemination Science (ACCORDS), University of Colorado Denver, Aurora. 2. Division of General Pediatrics, Department of Pediatrics, University of Colorado Denver, Aurora. 3. Center for Public Health Practice, Colorado School of Public Health, University of Colorado Denver, Aurora. 4. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. 5. Department of Biostatistics, Colorado School of Public Health, University of Colorado Denver, Aurora. 6. Division of Infectious Diseases, Department of Pediatrics, University of Colorado Denver, Aurora.
Abstract
Importance: The incidence of human papillomavirus (HPV)-related cancers is more than 35 000 cases in the United States each year. Effective HPV vaccines have been available in the United States for several years but are underused among adolescents, the target population for vaccination. Interventions to increase uptake are needed. Objective: To evaluate the effect of a 5-component health care professional HPV vaccine communication intervention on adolescent HPV vaccination. Design, Setting, and Participants: A cluster randomized clinical trial using covariate-constrained randomization to assign study arms and an intent-to-treat protocol was conducted in 16 primary care practices in the Denver, Colorado, metropolitan area. Participants included 188 medical professionals and 43 132 adolescents. Interventions: The 5 components of the intervention were an HPV fact sheet library to create customized information sheets relevant to each practice's patient population, a tailored parent education website, a set of HPV-related disease images, an HPV vaccine decision aid, and 2½ hours of communication training on using a presumptive vaccine recommendation, followed by motivational interviewing if parents were resistant to vaccination. Each practice participated in a series of 2 intervention development meetings over a 6-month period (August 1, 2014, to January 31, 2015) before the intervention. Main Outcomes and Measures: Differences between control and intervention changes over time (ie, difference in differences between the baseline and intervention period cohorts of patients) in HPV vaccine series initiation (≥1 dose) and completion (≥3 doses) among patients aged 11 to 17 years seen at the practices between February 1, 2015, and January 31, 2016. Vaccination data were obtained from the practices' records and augmented with state immunization information system data. Results:Sixteen practices and 43 132 patients (50.3% female; median age, 12.6 years [interquartile range, 10.8-14.7 years] at the beginning of the study period) participated in this trial. Adolescents in the intervention practices had significantly higher odds of HPV vaccine series initiation (adjusted odds ratio [aOR], 1.46; 95% CI, 1.31-1.62) and completion (aOR, 1.56; 95% CI, 1.27-1.92) than those in the control practices (a 9.5-absolute percentage point increase in HPV vaccine series initiation and a 4.4-absolute percentage point increase in HPV vaccine series completion in intervention practices). The intervention had a greater effect in pediatric practices compared with family medicine practices and in private practices compared with public ones. Health care professionals reported that communication training and the fact sheets were the most used and useful intervention components. Conclusions and Relevance: A health care professional communication intervention significantly improved HPV vaccine series initiation and completion among adolescent patients. Trial Registration: clinicaltrials.gov Identifier: NCT02456077.
RCT Entities:
Importance: The incidence of human papillomavirus (HPV)-related cancers is more than 35 000 cases in the United States each year. Effective HPV vaccines have been available in the United States for several years but are underused among adolescents, the target population for vaccination. Interventions to increase uptake are needed. Objective: To evaluate the effect of a 5-component health care professional HPV vaccine communication intervention on adolescent HPV vaccination. Design, Setting, and Participants: A cluster randomized clinical trial using covariate-constrained randomization to assign study arms and an intent-to-treat protocol was conducted in 16 primary care practices in the Denver, Colorado, metropolitan area. Participants included 188 medical professionals and 43 132 adolescents. Interventions: The 5 components of the intervention were an HPV fact sheet library to create customized information sheets relevant to each practice's patient population, a tailored parent education website, a set of HPV-related disease images, an HPV vaccine decision aid, and 2½ hours of communication training on using a presumptive vaccine recommendation, followed by motivational interviewing if parents were resistant to vaccination. Each practice participated in a series of 2 intervention development meetings over a 6-month period (August 1, 2014, to January 31, 2015) before the intervention. Main Outcomes and Measures: Differences between control and intervention changes over time (ie, difference in differences between the baseline and intervention period cohorts of patients) in HPV vaccine series initiation (≥1 dose) and completion (≥3 doses) among patients aged 11 to 17 years seen at the practices between February 1, 2015, and January 31, 2016. Vaccination data were obtained from the practices' records and augmented with state immunization information system data. Results: Sixteen practices and 43 132 patients (50.3% female; median age, 12.6 years [interquartile range, 10.8-14.7 years] at the beginning of the study period) participated in this trial. Adolescents in the intervention practices had significantly higher odds of HPV vaccine series initiation (adjusted odds ratio [aOR], 1.46; 95% CI, 1.31-1.62) and completion (aOR, 1.56; 95% CI, 1.27-1.92) than those in the control practices (a 9.5-absolute percentage point increase in HPV vaccine series initiation and a 4.4-absolute percentage point increase in HPV vaccine series completion in intervention practices). The intervention had a greater effect in pediatric practices compared with family medicine practices and in private practices compared with public ones. Health care professionals reported that communication training and the fact sheets were the most used and useful intervention components. Conclusions and Relevance: A health care professional communication intervention significantly improved HPV vaccine series initiation and completion among adolescent patients. Trial Registration: clinicaltrials.gov Identifier: NCT02456077.
Authors: L Miriam Dickinson; Brenda Beaty; Chet Fox; Wilson Pace; W Perry Dickinson; Caroline Emsermann; Allison Kempe Journal: J Am Board Fam Med Date: 2015 Sep-Oct Impact factor: 2.657
Authors: Lisa A McSherry; Stephan U Dombrowski; Jill J Francis; Judith Murphy; Cara M Martin; John J O'Leary; Linda Sharp Journal: Implement Sci Date: 2012-08-03 Impact factor: 7.327
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: A T Chamberlain; R J Limaye; S T O'Leary; P M Frew; S E Brewer; C I Spina; M K Ellingson; M Z Dudley; W A Orenstein; M A Donnelly; L E Riley; K A Ault; D A Salmon; S B Omer Journal: Vaccine Date: 2019-04-05 Impact factor: 3.641
Authors: Paula Anne Newman-Casey; Olivia Killeen; Sarah Miller; Chamisa MacKenzie; Leslie M Niziol; Ken Resnicow; John W Creswell; Paul Cook; Michele Heisler Journal: Health Commun Date: 2018-12-20
Authors: Melissa B Gilkey; Divya Mohan; Ellen M Janssen; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges Journal: Hum Vaccin Immunother Date: 2019-05-07 Impact factor: 3.452
Authors: Jenna E Reno; Jacob Thomas; Jennifer Pyrzanowski; Steven Lockhart; Sean T O'Leary; Elizabeth J Campagna; Amanda F Dempsey Journal: Hum Vaccin Immunother Date: 2019-01-16 Impact factor: 3.452
Authors: Parth D Shah; William A Calo; Melissa B Gilkey; Marcella H Boynton; Susan Alton Dailey; Karen G Todd; Meagan O Robichaud; Marjorie A Margolis; Noel T Brewer Journal: Pediatrics Date: 2019-01-22 Impact factor: 7.124
Authors: Mallory K Ellingson; Matthew Z Dudley; Rupali J Limaye; Daniel A Salmon; Sean T O'Leary; Saad B Omer Journal: Expert Rev Vaccines Date: 2019-01-28 Impact factor: 5.217
Authors: Melissa B Gilkey; Michael J Parks; Marjorie A Margolis; Annie-Laurie McRee; Jason V Terk Journal: Pediatrics Date: 2019-06-17 Impact factor: 7.124